LL-37 has been found to have contrasting effects on different types of cancers: for certain cancers, such as breast, lung and ovary cancer, LL-37 is tumorigenic and facilitates the cancer formation process, while in other cancers, like colon and gastric cancer, LL-37 has been proven to be anticancer. The gene discussed is CAMP; the disease is gastric cancer.